Biote (BTMD) Gains from Sales and Divestitures (2022 - 2026)

Biote (BTMD) has reported Gains from Sales and Divestitures for 5 consecutive years, with $7376.0 the latest figure, recorded in Q1 2026.

• In Q1 2026, Gains from Sales and Divestitures changed N/A year-over-year to $7376.0; the TTM figure through Mar 2026 stood at $7376.0 (changed N/A YoY), while the FY2025 annual figure was $24039.0, down 94.6% from the prior year.
• Gains from Sales and Divestitures came in at $7376.0 for Q1 2026 at Biote, down from $24039.0 in the prior quarter.
• The five-year high for Gains from Sales and Divestitures was $2.1 million in Q4 2022, with the low at $7376.0 in Q1 2026.
• Average Gains from Sales and Divestitures over 5 years is $554573.9, with a median of $435495.5 recorded in 2023.
• Across the five-year window, Gains from Sales and Divestitures increased 25.68% in 2023 and tumbled 94.6% in 2025, its largest moves.
• Year by year, Gains from Sales and Divestitures stood at $2.1 million in 2022, then sank by 39.11% to $1.3 million in 2023, then plunged by 64.43% to $444783.0 in 2024, then sank by 94.6% to $24039.0 in 2025, then sank by 69.32% to $7376.0 in 2026.
• According to Business Quant data, Gains from Sales and Divestitures over the past three periods registered $7376.0, $24039.0, and $24039.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.